乌尔索酸通过向EGFR/RAS/RAF/MAP2K1/MAPK1通路改善干眼中的眼表面功能障碍
Qinghe Zhang1, Ke Yan1, Yufei Lv1
1Department of Ophthalmology, The First Affiliated Hospital of University of South China, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.
Journal of pharmaceutical analysis
|December 16, 2025
概括
乌尔索酸 (UA) 眼滴有效治疗干眼 (DE) 通过减少炎症和保持眼睛表面健康. 这项研究确定了EGFR/RAS/RAF/MAP2K1/MAPK1通路是UA的关键.
科学领域:
- 眼科和药理学 眼科和药理学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 干眼 (DE) 是一种炎症性眼表面疾病.
- 炎症是DE的中心病理因素.
- 乌尔索酸 (UA) 具有已知的抗炎性质.
研究的目的:
- 评估UA对干眼 (DE) 的治疗效果.
- 阐明UA在治疗DE的基础分子机制.
- 评估UA对眼睛表面细胞和动物模型的保护作用.
主要方法:
- 已确立的超体应激和动物模型用于DE.
- 使用红棉试验和裂纹灯检查进行损伤评估.
- 采用数据库挖掘,PPI网络分析,分子对接和整合性奥米克分析 (scRNA-seq,RNA-seq).
主要成果:
- UA眼滴保留了眼睛表面的完整性,并减轻了DE的症状.
- 网络药理学确定了EGFR/RAS/RAF/MAP2K1/MAPK1通路作为一个关键目标.
- scRNA-seq证实了通路蛋白在眼前部分,特别是角膜的局部化.
结论:
- UA眼滴显示出对干眼的显著治疗潜力.
- EGFR/RAS/RAF/MAP2K1/MAPK1通路对于UA在DE中的疗效至关重要.
- UA为眼睛表面疾病提供了一个有前途的治疗策略.
相关概念视频
01:28Angle Closure Glaucoma: Treatment
1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K
01:27Open Angle Glaucoma: Treatment
928
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
928